02124nam a2200349Ia 4500001001200000003000600012005001700018007001400035008004100049040006300090043001200153074001600165086002900181110016800210245023400378260008500612300002800697336002600725337002700751338003100778490002300809500003600832500002500868533009300893610003600986650007001022650006801092650005201160776025901212776024301471810006001714ocm83253744OCoLC20171208174542.0he bmb024bbca070213s2006    dcu     b    f000 0 eng d  aFPSbengcFPSdOCLCFdOCLCOdOCLCQdOCLCOdOCLCQdGPOdMvI  an-us---  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.109-7001 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aRecent controversies in stem cell research :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, second session, special hearing, September 6, 2006, Washington, DC.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O.,c2006.  aiii, 21 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v109-700  aShipping list no.: 2007-0082-M.  aCRDP Program record.  aMicrofiche.bWashington :cSupt. of Docs., U.S. G.P.O.,d2007.e1 microfiche : negative.20aAdvanced Cell Technology (Firm) 0aHuman embryoxResearchxMoral and ethical aspectszUnited States. 0aStem cellsxResearchxMoral and ethical aspectszUnited States. 0aFederal aid to medical researchzUnited States.08iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tRecent controversies in stem cell researchw(DLC) 2007361317w(OCoLC)7695105208iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tRecent controversies in stem cell researchw(OCoLC)6474910491 aUnited States.bCongress.bSenate.tS. hrg. ;v109-700.